Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas

Published:2018-09-26 Issue:12 Volume:18 Page:1241-1248
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Jones Robin L.¹,Le Cesne Axel²,Ibrahim Tony²,Garcia del Muro Xavier³,Menge Franka⁴

Affiliation:

1. Sarcoma Unit, Royal Marsden Hospital, Institute of Cancer Research, London, UK

2. Department of Medical Oncology, Gustave Roussy, Villejuif, France

3. Medical Oncology Department, Institute Catalan of Oncology, Barcelona, Spain

4. Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany

Funder

PharmaMar SA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1524298

Reference24 articles.

1. Article Commentary: Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)

2. The Cancer Patient and Quality of Life

3. Health-related quality of life and cancer clinical trials

4. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

5. Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas;Frontiers in Oncology;2024-07-25

2. Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes;Future Oncology;2022-09

3. Keeping the balance, the true major goal in advanced sarcoma;Future Oncology;2021-07

4. Doxorubicin/ifosfamide/trabectedin;Reactions Weekly;2018-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3